Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Reg...
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
The simultaneous administration of three antiplatelet agents has been proposed as an efficient strategy for the secondary prevention of atherothrombotic events and is included in the European guidelines. However, this strategy presented an increased risk of bleeding; therefore, the identification of new antiplatelet agents, with improved efficacy a...
Alternative Titles
Full title
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6f867f58fe2047f996fcbceb46574166
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6f867f58fe2047f996fcbceb46574166
Other Identifiers
ISSN
1420-3049
E-ISSN
1420-3049
DOI
10.3390/molecules28052311
